ライフサイエンスコーパス: ejaculatory

1 erse dialysis of 5-HT into the MPOA impaired ejaculatory ability and attenuated glutamate release.

2 evelopment of new instruments to investigate ejaculatory and orgasmic disorders.

3 formed a purely psychoanalytical approach to ejaculatory and orgasmic function into a novel multidisc

4 athophysiology, neuroscience and genetics of ejaculatory and orgasmic function will eventually lead t

5 cells plays a pivotal role in generation of ejaculatory behavior and may be part of a spinal ejacula

6 iosus muscle, which mediates ejaculation and ejaculatory behavior, is markedly diminished in mice wit

7 saporin resulted in a complete disruption of ejaculatory behavior.

8 In males, cVA colocalizes at the tip of the ejaculatory bulb with a second acetylated hydrocarbon na

9 specific sex pheromones were detected in the ejaculatory bulb, a specialized site of pheromone produc

10 s are secreted exclusively by males from the ejaculatory bulb, transferred to females during mating,

11 geted to treat neurogenic and non-neurogenic ejaculatory disorders.

12 One of these pairs, the male ejaculatory duct and female oviduct, are known to be dev

13 el of the evolution of Gld expression in the ejaculatory duct and oviduct is presented.

14 We surveyed the growing literature on ejaculatory duct obstruction and provide suggestions reg

15 Ejaculatory duct obstruction is a rare but surgically co

16 Ejaculatory duct obstruction is a rare cause of male inf

17 re no pathognomonic findings associated with ejaculatory duct obstruction, the diagnosis should be su

18 ricle (not in the patient with hypospadias), ejaculatory duct reflux, internal urachal sinus, and lip

19 s in males causes atresia of the homolateral ejaculatory duct that results in obstruction of the prox

20 tivates a heterologous hsp70 promoter in the ejaculatory duct, but not in other reproductive tract ti

21 The ejaculatory duct/oviduct enhancer retains the ability to

22 61-nt region of the SREC that is involved in ejaculatory duct/oviduct-specific expression.

23 luation of infertility in men with suspected ejaculatory-duct obstruction.

24 spond best to transurethral resection of the ejaculatory ducts (TURED).

25 n-positive areas frequently located close to ejaculatory ducts and negative for prostatic-specific an

26 n of the vas deferens, seminal vesicles, and ejaculatory ducts by calcification or fibrosis in 43 (15

27 ctive tract (vas deferens, seminal vesicles, ejaculatory ducts).

28 Epithelial cells of prostatic glands, ejaculatory ducts, and seminal vesicles expressed E-cadh

29 cysts of the seminal vesicles, vas deferens, ejaculatory ducts, or prostate in 26 (9.4%) patients; an

30 ot detected in the basal cell layer, stroma, ejaculatory ducts, seminal vesicles, or transitional epi

31 epithelial cells of the seminal vesicles and ejaculatory ducts.

32 Ejaculatory dysfunction is common and may cause substant

33 an independent risk factor for erectile and ejaculatory dysfunction.

34 ation between LUTS, erectile dysfunction and ejaculatory dysfunction.

35 ire, sexual function, including erectile and ejaculatory function, and sexual satisfaction before, du

36 % reported impairment in erectile and 22% in ejaculatory function.

37 dala was positively correlated with the post-ejaculatory interval.

38 hey had lower intromission ratios and longer ejaculatory latencies.

39 The primary endpoint was intravaginal ejaculatory latency time (IELT) measured by stopwatch.

40 The intravaginal ejaculatory latency time remains the primary measure of

41 ing cardiovascular function, bowel motility, ejaculatory latency, and bladder control.

42 The urethrogenital (UG) reflex is a spinal ejaculatory-like reflex.

43 mental intraspinal circuitry responsible for ejaculatory-like responses and demonstrate the potential

44 e of men reporting posttreatment erectile or ejaculatory problems remained higher than baseline, alth

45 is marked by a mixture of pain, urinary, and ejaculatory symptoms with no uniformly effective therapy

46 the medial preoptic area (MPOA), reduces the ejaculatory threshold in male rats.

47 latency time remains the primary measure of ejaculatory time although increasing bother and distress